Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(OP:AVAI)

0.4981 UNCHANGED
Streaming Delayed Price Updated: 3:53 PM EDT, Mar 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 51
Open 0.4981
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.4981
Today's Range 0.4981 - 0.4981
52wk Range 0.2191 - 1.500
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
AI Influence on Medical Diagnostics Generating Billion Dollar Revenues While Growing Adoption Reduces Healthcare Costs
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:TEM),(NYSE:TDOC),(NASDAQ:TALK),(NASDAQ:BFRG) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Avant Technologies and Ainnova Begin Designing Clinical Trial Protocol for Company’s Vision AI Platform
Las Vegas, NV – March 25, 2025 – Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), and its partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on... 
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety

Performance

YTD
+2.7%
+2.7%
1 Month
+18.6%
+18.6%
3 Month
-6.0%
-6.0%
6 Month
-0.4%
-0.4%
1 Year
-50.7%
-50.7%

More News

Read More
AI Influence on Medical Diagnostics Generating Billion Dollar Revenues While Growing Adoption Reduces Healthcare Costs
From FN Media Group LLC
Via GlobeNewswire
Avant Technologies and Ainnova Begin Designing Clinical Trial Protocol for Company's Vision AI Platform
Via ACCESS Newswire
Artificial Intelligence Influence on Healthcare Industry Reaching All Time Highs for Diagnostics and Treatments
From FN Media Group LLC
Via GlobeNewswire
Artificial Intelligence Influence on Healthcare Industry Reaching All Time Highs for Diagnostics and Treatments
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence
Avant Technologies and JV Partner, Ainnova, Strategically Align with Apollo Hospitals to Advance AI in Healthcare
Via ACCESS Newswire
Avant Technologies and JV Partner, Ainnova, Strategically Align with Apollo Hospitals to Advance AI in Healthcare
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence
Avant Technologies Reaches Global Development and Licensing Deal with Partner, Ainnova Tech, Ahead of FDA Meetings
Via ACCESS Newswire
Avant Technologies JV Partner to Speak at AI Revolution in Healthcare Summit in Dubai
Via ACCESS Newswire
Artificial Intelligence (AI) Influence on Healthcare Market Expected to Generate Revenues of $610 Billion By 2034
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Avant Technologies and Ainnova Advance Toward FDA Clinical Trial with Selection of Top CRO
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Artificial Intelligence (AI) Influence on Healthcare Market Expected to Generate Revenues of $610 Billion By 2034
From FN Media Group LLC
Via GlobeNewswire
Avant Technologies and Ainnova Advance Toward FDA Clinical Trial with Selection of Top CRO
Via ACCESS Newswire
Avant Technologies to Play Key Role in Ainnova's U.S. FDA Clinical Study for Its Vision AI Platform
Via TheNewswire.com
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Avant Technologies to Play Key Role in Ainnova's U.S. FDA Clinical Study for Its Vision AI Platform
Via NewMediaWire
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
How HealthCare Industry is Leveraging Artificial Intelligence to Revolutionize Diagnostics and Early Disease Detection
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19
Avant Technologies and Ainnova Begin Implementing and Testing Advanced AI Algorithms for Early Detection of Additional Diseases
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence
Avant Technologies and Ainnova Begin Implementing and Testing Advanced AI Algorithms for Early Detection of Additional Diseases
Via NewMediaWire
Topics Artificial Intelligence
Exposures Artificial Intelligence
Avant Technologies and Ainnova Begin Implementing and Testing Advanced AI Algorithms for Early Detection of Additional Diseases
Via TheNewswire.com
Topics Artificial Intelligence
Exposures Artificial Intelligence
The Next Wave of Health AI: Analysts Highlight Breakthroughs in Clinical Trials and Patient Care
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Avant Technologies and Ainnova Secure Advanced AI Algorithms for Early Detection of Four Additional Diseases in the U.S.
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why Healthcare Providers Are Increasingly Trusting Artificial Intelligence for Detection & Diagnosis
Via FinancialNewsMedia
Topics Artificial Intelligence Climate Change
Exposures Artificial Intelligence Climate
The Intersection of AI, Medicine, and Stocks: A New Era of Opportunities
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why Healthcare Providers Are Increasingly Trusting Artificial Intelligence for Detection & Diagnosis
From FN Media Group LLC
Via GlobeNewswire

Frequently Asked Questions

Is AVAI publicly traded?
Yes, AVAI is publicly traded.
What exchange does AVAI trade on?
AVAI trades on the OTC Traded
What is the ticker symbol for AVAI?
The ticker symbol for AVAI is AVAI on the OTC Traded
What is the current price of AVAI?
The current price of AVAI is 0.4981
When was AVAI last traded?
The last trade of AVAI was at 03/26/25 03:53 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.